Science | ABNewswire

Author Joshua Quentin Hawk Explores Survival, Memory, and Rebirth in a Stunning New Sci-Fi Epic

Cover art for The Lost Outpost by Joshua Quentin Hawk. The imagery reflects the themes of memory, exploration, and the vast unknown of space. The Lost Outpost, the debut sci-fi novel by Joshua Quentin Hawk, follows a mission commander who … Continue reading →

Counseling Services for Wellbeing Tackles Washington’s Mental Health Access Crisis with a Unified Care Model

With coordinated care, quicker access, and a deeply personal approach, Counseling Services for Wellbeing is changing what it means to get meaningful mental health help in Washington Washington state has joined a national trend of rising mental health needs, worsened … Continue reading →

Food Allergy Pipeline Insights Report 2025: Clinical Trial Progress, Breakthrough Drugs, and Companies Shaping the Future of Treatment | DelveInsight

DelveInsight’s “Food Allergy Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Food Allergy pipeline landscape. It covers the Food Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Myocardial Infarction Pipeline Drugs Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s, “Myocardial Infarction Pipeline Insight 2025” report provides comprehensive insights about 30+ companies and 40+ pipeline drugs in Myocardial Infarction pipeline landscape. It covers the Myocardial Infarction pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Epilepsy Pipeline Drugs Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s “Epilepsy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 90+ pipeline drugs in the Epilepsy pipeline landscape. It covers the Epilepsy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Epilepsy pipeline … Continue reading →

Major Depressive Disorder Pipeline Insights Report 2025: Emerging Drugs, Ongoing Clinical Trials, and Leading Companies Transforming the Treatment Landscape | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

RheeGen and Winback Announce Strategic Partnership to Advance Topical Regenerative & TECAR-Based Recovery Technologies

Dr. Tommy Rhee RheeGen®, a pioneering leader in cell-free topical regenerative therapy, announced today a strategic partnership with Winback, a global innovator in TECAR energy and electrotherapy technologies. Tampa, FL – Nov 10, 2025 – RheeGen®, a pioneering leader in cell-free … Continue reading →

Read My MRI Launches Read My Labs to Provide Clear, Patient-Friendly Lab Result Summaries

Read My MRI Launches Read My Labs Read My MRI has launched Read My Labs, a new AI-powered service that explains blood test results in clear, everyday language. The service is designed to help patients understand their lab reports and … Continue reading →

Chronic Traumatic Encephalopathy Pipeline Drugs Report 2025: Companies Accelerate Drug Development Through Advanced Clinical Trials Targeting Effective Treatment Solutions | DelveInsight

DelveInsight’s “Chronic Traumatic Encephalopathy Pipeline Insight 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Chronic Traumatic Encephalopathy pipeline landscape. It covers the Chronic Traumatic Encephalopathy Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Heart Failure Pipeline Insights Report 2025: Novel Treatment Approaches and Clinical Trial Insights from Top Pharma Companies | DelveInsight

DelveInsight’s, “Heart Failure Pipeline Insight 2025” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Heart Failure pipeline landscape. It covers the Heart Failure pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Tuesday - November 25, 2025

Category Archives: Science